Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 3.44B | 3.55B | 3.55B | 3.92B | 4.92B | 4.13B |
Gross Profit | 991.20M | 850.50M | 657.30M | 982.60M | 1.49B | 1.35B |
EBITDA | 312.00M | 215.80M | -174.40M | -336.90M | 845.80M | 684.90M |
Net Income | 53.10M | -34.90M | -380.10M | -437.50M | 512.50M | 387.40M |
Balance Sheet | ||||||
Total Assets | 3.09B | 2.87B | 3.41B | 4.30B | 4.80B | 3.38B |
Cash, Cash Equivalents and Short-Term Investments | 51.10M | 71.60M | 31.90M | 86.80M | 244.10M | 16.60M |
Total Debt | 2.19B | 2.52B | 2.91B | 3.27B | 2.60B | 1.68B |
Total Liabilities | 3.26B | 3.26B | 3.68B | 4.15B | 3.79B | 2.68B |
Stockholders Equity | -170.90M | -390.60M | -267.30M | 147.70M | 1.01B | 702.90M |
Cash Flow | ||||||
Free Cash Flow | 244.60M | 583.50M | 438.20M | -242.50M | 164.60M | 495.30M |
Operating Cash Flow | 315.70M | 667.50M | 531.00M | -129.00M | 271.50M | 558.00M |
Investing Cash Flow | -80.40M | -100.40M | -65.70M | -283.20M | -538.60M | 46.90M |
Financing Cash Flow | -465.00M | -527.90M | -520.10M | 255.30M | 494.00M | -607.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | 14.92B | 12.04 | 26.23% | 2.17% | 9.53% | 36.15% | |
65 Neutral | 11.21B | 11.98 | 7.56% | 2.46% | -7.71% | 297.49% | |
63 Neutral | 7.86B | 21.41 | 6.10% | 2.93% | -1.22% | -14.31% | |
58 Neutral | 4.20B | 42.70 | 2.24% | 6.90% | 1.16% | -92.85% | |
52 Neutral | $3.24B | 73.02 | 4.98% | 4.71% | -2.05% | ― | |
45 Neutral | 4.65M | -0.62 | -113.10% | ― | 1.50% | -8.01% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
On August 28, 2025, The Scotts Miracle-Gro Company amended its Master Receivables Purchase Agreement with JPMorgan Chase Bank to extend the purchase termination date to September 1, 2026. This amendment allows the company to sell up to $750 million in customer accounts receivable, which will continue to be serviced by the company for a fee, and the proceeds will be used for general corporate purposes.
The most recent analyst rating on (SMG) stock is a Hold with a $62.00 price target. To see the full list of analyst forecasts on Scotts Miracle-Gro Company stock, see the SMG Stock Forecast page.